UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atogepant for the Preventive Treatment of Migraine

The New England journal of medicine, 2021-08, Vol.385 (8), p.695-706

2021

Volltextzugriff (PDF)

Italian Guidelines for the Management of Non-Functioning Benign and Locally Symptomatic Thyroid Nodules

Endocrine, metabolic & immune disorders drug targets, 2023-01, Vol.23 (6), p.876-885

2023

Volltextzugriff (PDF)

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2023-09, Vol.402 (10404), p.775-785

2023

Volltextzugriff (PDF)

Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial

Cephalalgia, 2022-01, Vol.42 (1), p.3-11

2022

Volltextzugriff (PDF)

Atogepant Significantly Reduces Mean Monthly Migraine Days in the Phase 3 Trial (ADVANCE) for the Preventive Treatment of Migraine (1494)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial

Headache, 2023-01, Vol.63 (1), p.79-88

2023

Volltextzugriff (PDF)

Long-term Safety and Tolerability of Atogepant 60 mg Following Once Daily Dosing Over 1 Year for the Preventive Treatment of Migraine (2664)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults

Cephalalgia, 2019-12, Vol.39 (14), p.1753-1761

2019

Volltextzugriff (PDF)

Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial

Cephalalgia, 2023-01, Vol.43 (1), p.3331024221128250-3331024221128250

2023

Volltextzugriff (PDF)

Atogepant 60 mg Once-Daily Shows Efficacy for the Preventive Treatment of Migraine: Results From a 52-Week Open-Label Extension Trial (P1-2.001)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Evaluation of the Long-Term Safety and Tolerability of Oral Atogepant 60 Mg Once Daily for Preventive Treatment of Migraine: A Phase 3, 40-Week, Multicenter Extension to the Advance Trial (P3-2.001)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Open forum infectious diseases, 2019-01, Vol.6 (1), p.ofy331

2019

Volltextzugriff (PDF)

Safety and Tolerability of Ubrogepant Following Intermittent, High Frequency Dosing (S17.009)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial

JAMA network open, 2022-06, Vol.5 (6), p.e2215499-e2215499

2022

Volltextzugriff (PDF)

Linea guida per la gestione del nodulo benigno della tiroide causa di sintomi locali: Associazione medici endocrinologi (AME), Istituto superiore di Sanità 2022 e Associazione Italiana della Tiroide (AIT); Associazione Italiana di Medicina Nucleare (AIMN); Associazione Nazionale Infermieri in Endocrinologia e Diabetologia (ANIED); Comitato Associazioni Pazienti Endocrini (CAPE); Federazione delle Associazioni dei Dirigenti Medici Ospedalieri Internisti (FADOI); Società Italiana di Anatomia Patologica e Citologia Diagnostica - Divisione Italiana della International Academy of Path

L'Endocrinologo, 2023-06, Vol.24 (3), p.285-295

2023

Volltextzugriff (PDF)

Linea guida per la gestione del nodulo benigno della tiroide causa di sintomi locali

L'Endocrinologo, 2023-01, Vol.24 (3), p.285-295

2023

Volltextzugriff (PDF)

Impact of carbon monoxide partial pressures on methanogenesis and medium chain fatty acids production during ethanol fermentation

Biotechnology and bioengineering, 2018-02, Vol.115 (2), p.341-350

2018

Volltextzugriff (PDF)

Selective enrichment yields robust ethene-producing dechlorinating cultures from microcosms stalled at cis-dichloroethene

PloS one, 2014-06, Vol.9 (6), p.e100654

2014

Volltextzugriff (PDF)

Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells

PloS one, 2017-02, Vol.12 (2), p.e0171362-e0171362

2017

Volltextzugriff (PDF)

Characterization of kefir-like beverages produced from vegetable juices

Food science & technology, 2016-03, Vol.66, p.572-581

2016

Volltextzugriff (PDF)

Battery Models for Battery Powered Applications: A Comparative Study

Energies (Basel), 2020-08, Vol.13 (16), p.4085

2020

Volltextzugriff (PDF)

Enrichment and Analysis of Anode-Respiring Bacteria from Diverse Anaerobic Inocula

Environmental science & technology, 2012-09, Vol.46 (18), p.10349-10355

2012

Volltextzugriff (PDF)

Acceptance of biometric technology in airport check-in

Journal of air transport management, 2019-10, Vol.81, p.101720, Article 101720

2019

Volltextzugriff (PDF)

Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation

PloS one, 2019-07, Vol.14 (7), p.e0219597-e0219597

2019

Volltextzugriff (PDF)

Disasters and Cultural Heritage: planning for prevention, emergency management and risk reduction

IOP conference series. Materials Science and Engineering, 2020-11, Vol.949 (1), p.12084

2020

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(107)
Italienisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Atogepant for the Preventive Treatment of Migraine

Italian Guidelines for the Management of Non-Functioning Benign and Locally Symptomatic Thyroid Nodules

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial

Atogepant Significantly Reduces Mean Monthly Migraine Days in the Phase 3 Trial (ADVANCE) for the Preventive Treatment of Migraine (1494)

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial

Long-term Safety and Tolerability of Atogepant 60 mg Following Once Daily Dosing Over 1 Year for the Preventive Treatment of Migraine (2664)

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults

Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial

Atogepant 60 mg Once-Daily Shows Efficacy for the Preventive Treatment of Migraine: Results From a 52-Week Open-Label Extension Trial (P1-2.001)

Evaluation of the Long-Term Safety and Tolerability of Oral Atogepant 60 Mg Once Daily for Preventive Treatment of Migraine: A Phase 3, 40-Week, Multicenter Extension to the Advance Trial (P3-2.001)

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Safety and Tolerability of Ubrogepant Following Intermittent, High Frequency Dosing (S17.009)

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial

Linea guida per la gestione del nodulo benigno della tiroide causa di sintomi locali

Impact of carbon monoxide partial pressures on methanogenesis and medium chain fatty acids production during ethanol fermentation

Selective enrichment yields robust ethene-producing dechlorinating cultures from microcosms stalled at cis-dichloroethene

Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells

Characterization of kefir-like beverages produced from vegetable juices

Battery Models for Battery Powered Applications: A Comparative Study

Enrichment and Analysis of Anode-Respiring Bacteria from Diverse Anaerobic Inocula

Acceptance of biometric technology in airport check-in

Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation

Disasters and Cultural Heritage: planning for prevention, emergency management and risk reduction

Suchergebnisse filtern